Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Closure of Certain Special Accounts for Raised Funds

Sep 19, 2026 · Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Closure of Certain Special Accounts for Raised Funds

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of Progress of Phase I Clinical Trials for EP-0226 TabletsSep 17
"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Resolutions of the 16th Meeting of the 4th Board of DirectorsSep 12
"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 9
"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Sep 8

All Chengdu Easton Biopharmaceuticals Co., Ltd. Class A news releases